Litcius/Paper detail

Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases

J. Rigal, Jonathan Ciron, Zoé Lepine, Damien Biotti

2020Multiple Sclerosis and Related Disorders30 citationsDOI

Topics & Concepts

MedicineRituximabNeuromyelitis opticaNeutropeniaMultiple sclerosisAsymptomaticSpectrum disorderPediatricsInternal medicineDermatologyImmunologyChemotherapyLymphomaPsychiatryNeutrophil, Myeloperoxidase and Oxidative MechanismsMultiple Sclerosis Research StudiesImmune Response and Inflammation
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases | Litcius